I agree that this site is using cookies. You can find further informations here.
X
Jackisch, C.
167  results:
english X
Search for persons X
?
1

114P Fixed-dose combination of pertuzumab and trastuzumab f..:

Jackisch, C. ; Im, S-A. ; Mattar, A....
ESMO Open.  9 (2024)  - p. 103102 , 2024
Link: https://doi.org/10.1016/..
 
?
2

216P What is driving treatment decision following 1st line ..:

Lüftner, D.I. ; Brucker, C. ; Dawkins, L.S.M....
ESMO Open.  9 (2024)  - p. 103238 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P014 Interim analysis of ELEANOR (n = 200): a multi-nationa..:

Bartsch, R. ; Harbeck, N. ; Wrobel, D....
The Breast.  68 (2023)  - p. S20-S21 , 2023
Link: https://doi.org/10.1016/..
 
?
4

109P Updated long-term overall survival of older adjuvant i..:

Schmidt, M. ; Nitz, U.A. ; Reimer, T....
ESMO Open.  8 (2023)  1 - p. 101333 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P262 How patients prioritize features of different potentia..:

Jackisch, C. ; Mulvihill, E. ; Flood, E....
The Breast.  68 (2023)  - p. S119-S120 , 2023
Link: https://doi.org/10.1016/..
 
?
6

285 Clinical management of placenta percreta non-previa wit..:

Kalfoutzos, K. ; Argyriadis, A. ; Joechel, E....
European Journal of Obstetrics & Gynecology and Reproductive Biology.  270 (2022)  - p. e20 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Extended adjuvant treatment of patients with HER2+ early br..:

Bartsch, R. ; Lüftner, D. ; Balic, M....
The Breast.  56 (2021)  - p. S18 , 2021
Link: https://doi.org/10.1016/..
 
?
8

The REMAR (Rhein-Main-Registry)-Study: Prospective evaluati..:

Thill, M. ; Anastasiadou, L. ; Solbach, C....
European Journal of Cancer.  138 (2020)  - p. S92-S93 , 2020
Link: https://doi.org/10.1016/..
 
?
9

SERIOUS ADVERSE EVENTS AMONG OLDER PATIENTS IN THE ALTTO TR..:

Pondé, N. ; Tarh, D.Agbor ; Korde, L....
Journal of Geriatric Oncology.  10 (2019)  6 - p. S14-S15 , 2019
Link: https://doi.org/10.1016/..
 
?
10

The use of bisphosphonates in the management of bone involv..:

Lebret, T. ; Casas, A. ; Cavo, M....
European Journal of Cancer Care.  26 (2016)  4 - p. e12490 , 2016
Link: https://doi.org/10.1111/..
 
?
11

Zoledronate for patients with invasive residual disease aft..:

von Minckwitz, G. ; Rezai, M. ; Tesch, H....
European Journal of Cancer.  64 (2016)  - p. 12-21 , 2016
Link: https://doi.org/10.1016/..
 
?
12

1869 Disease characteristics of subgroup patients treated w..:

Lüftner, D. ; Grischke, E.M. ; Fasching, P....
European Journal of Cancer.  51 (2015)  - p. S288-S289 , 2015
Link: https://doi.org/10.1016/..
 
?
13

1945 Phase III HannaH study of subcutaneous or intravenous ..:

Jackisch, C. ; Hegg, R. ; Stroyakovskiy, D....
European Journal of Cancer.  51 (2015)  - p. S313-S314 , 2015
Link: https://doi.org/10.1016/..
 
?
14

1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib..:

Untch, M. ; Von Minckwitz, G. ; Gerber, B....
European Journal of Cancer.  51 (2015)  - p. S264 , 2015
Link: https://doi.org/10.1016/..
 
?
15

P201 Subcutaneous versus intravenous trastuzumab in early b..:

Jackisch, C. ; Hegg, R. ; Stroyakovskiy, D....
The Breast.  24 (2015)  - p. S94 , 2015
Link: https://doi.org/10.1016/..
 
1-15